You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 43 No. 8, August 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  NEUROLOGICAL REVIEW
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (80)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Postherpetic Neuralgia

A Review

Peter N. Watson, MD, FRCP(C); Ramon J. Evans, MD, FRCS(C)

Arch Neurol. 1986;43(8):836-840.


Abstract

• Postherpetic pain persisting one month or longer occurs in 9% to 14% of patients with herpes zoster, diminishing with time. The incidence and duration are directly related to age. The pathologic features have been described but the pathogenesis of postherpetic neuralgia is unknown. Treatment remains difficult. It is reasonable to hope for a reduction in pain from severe to mild in two of three cases. There is evidence to support the use of low doses of tricyclic antidepressants, especially amitriptyline hydrochloride, with gradual small increments, and also the use of phenothiazines. Corticosteroids may exert a preventive effect when used in the acute phase. There is some support for the use of local physical modalities. Neurosurgical procedures are a possibility in failed medical cases. Controlled studies of newer approaches are necessary.



Author Affiliations

From the Irene Eleanor Smythe Pain Clinic, University of Toronto General Hospital.


Footnotes

Accepted for publication April 10, 1986.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Herpes Zoster Overview: Natural History and Incidence
Weaver
JAOA: Journal of the American Osteopathic Association 2009;109:S2-S6.
ABSTRACT | FULL TEXT  

Practice Parameter: Treatment of postherpetic neuralgia: An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology
Dubinsky et al.
Neurology 2004;63:959-965.
ABSTRACT | FULL TEXT  

Varicella-Zoster Virus Productively Infects Mature Dendritic Cells and Alters Their Immune Function
Morrow et al.
J. Virol. 2003;77:4950-4959.
ABSTRACT | FULL TEXT  

Risk Factors for Postherpetic Neuralgia
Choo et al.
Arch Intern Med 1997;157:1217-1224.
ABSTRACT  

Antiepileptics in the Elderly: Pharmacoepidemiology and Pharmacokinetics
Cloyd et al.
Arch Fam Med 1994;3:589-598.
ABSTRACT  

A Randomized Trial of Acyclovir for 7 Days or 21 Days with and without Prednisolone for Treatment of Acute Herpes Zoster
Wood et al.
NEJM 1994;330:896-900.
ABSTRACT | FULL TEXT  

Topical Aspirin in Chloroform and the Relief of Pain due to Herpes Zoster and Postherpetic Neuralgia
King
Arch Neurol 1993;50:1046-1053.
ABSTRACT  

Clinical and Biological Differences Between Recurrent Herpes Simplex Virus and Varicella-Zoster Virus Infections
Straus
JAMA 1989;262:3455-3458.
ABSTRACT  

Varicella-Zoster Virus Infections: Biology, Natural History, Treatment, and Prevention
STRAUS et al.
ANN INTERN MED 1988;108:221-237.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.